UPL acquires naturally-derived fungicide, OptiCHOS to strengthen biocontrol portfolio

Image
Capital Market
Last Updated : May 04 2022 | 5:04 PM IST

UPL on Wednesday announced that its group has acquired OptiCHOS, a naturally derived fungicide for its Natural Plant Protection (NPP) business unit, whose NPP portfolio houses natural and biologically derived agricultural inputs and technologies.

NPP is a global operating entity housing UPL's portfolio of natural and biologically derived agricultural inputs and technologies.

OptiCHOS offers farmers a new, low-risk, residue free and bio-degradable broad spectrum disease control solution, with low environmental and human impacts. The active ingredients of OptiCHOS were developed from the chitin-rich by-products of the shellfish industry by BioCHOS, a spin-off of the Norwegian University of Life Sciences. NPP's acquisition of OptiCHOS includes the registration data package and patents enabling the product to be used in mixture of a wide range of fungicides, providing the agricultural industry a variety of options.

The fugicide has already been submitted for approval for use in the European Union and NPP expects to be able to launch OptiCHOS products across the bloc in the next few years. Outside the EU, UPL will identify other markets for OptiCHOS and launch registration and approval processes to make the product available to farmers, company stated.

OptiCHOS will be integrated into UPL's ProNutiva programme which integrates naturally based biosolutions with conventional crop protection products to offer farmers tailored and adaptable packages that directly tackles pain-points. Through this programme, farmers can ensure higher yields with lower environmental impact while also improving their economic resilience and sustainability, the company further added.

UPL is a global provider of sustainable agriculture products and solutions. Its portfolio consists of biologicals and traditional crop protection solutions with more than 14,000 registrations.

The company's consolidated net profit rose 24.89% to Rs 1,179 crore on a 23.78% increase in revenue from operations to Rs 11,297 crore in Q3 FY22 over Q3 FY21.

Shares of UPL fell 0.87% to Rs 822.45 on BSE.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 04 2022 | 3:52 PM IST

Next Story